Role of raloxifene in the management of postmenopausal osteoporosis of rheumatoid arthritis patients
Due to the severe side effects of long-term treatment using hormone replacement therapy, Raloxifene (RLX) is introduced with beneficial effects on rheumatoid arthritis (RA) for postmenopausal women. This review was conducted to collect data from the available literature on RLX for the management of...
Saved in:
Main Authors: | Salari M. (Author), Sahebary M. (Author), Sarafraz M. (Author), Asadi Sakhmarresi T. (Author) |
---|---|
Format: | Book |
Published: |
Sciendo,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006) -
Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
by: Enrico M Messalli, et al.
Published: (2009) -
Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
by: Toda A, et al.
Published: (2017) -
Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels
by: Saliha Karatay, et al.
Published: (2005) -
The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006)